Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Net Cash Flow (2022 - 2026)

Zentalis Pharmaceuticals has reported Net Cash Flow over the past 5 years, most recently at -$4.1 million for Q1 2026.

  • For Q1 2026, Net Cash Flow fell 150.64% year-over-year to -$4.1 million; the TTM value through Mar 2026 reached -$10.0 million, down 334.77%, while the annual FY2025 figure was $2.1 million, 63.95% down from the prior year.
  • Net Cash Flow for Q1 2026 was -$4.1 million at Zentalis Pharmaceuticals, down from -$3.1 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $230.3 million in Q2 2023 and troughed at -$155.8 million in Q3 2023.
  • A 5-year average of -$1.6 million and a median of -$3.1 million in 2025 define the central range for Net Cash Flow.
  • On a YoY basis, Net Cash Flow climbed as much as 846.56% in 2023 and fell as far as 16057.34% in 2023.
  • Year by year, Net Cash Flow stood at $518000.0 in 2022, then plummeted by 16057.34% to -$82.7 million in 2023, then soared by 91.02% to -$7.4 million in 2024, then soared by 58.53% to -$3.1 million in 2025, then crashed by 32.11% to -$4.1 million in 2026.
  • Business Quant data shows Net Cash Flow for ZNTL at -$4.1 million in Q1 2026, -$3.1 million in Q4 2025, and $1.5 million in Q3 2025.